Avroxa, Besloten Vennootschap – Trademark Portfolio
Entity Type: 99
Avroxa, Besloten Vennootschap holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ULTRAPEI. The owner is based in Gent.
Technologiepark-Zwijnaarde 82
Gent B-9052 , BE
Showing of trademarks Trademarks
Trademark Classifications
Avroxa, Besloten Vennootschap's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Avroxa, Besloten Vennootschap have?
Avroxa, Besloten Vennootschap has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does Avroxa, Besloten Vennootschap file in?
Avroxa, Besloten Vennootschap files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Avroxa, Besloten Vennootschap's most well-known trademarks?
Avroxa, Besloten Vennootschap's registered trademark portfolio includes well-known marks such as ULTRAPEI. These are among 1 currently registered trademark in the portfolio.
What is Avroxa, Besloten Vennootschap's trademark registration success rate?
Avroxa, Besloten Vennootschap has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.